The Journal of Steroid Biochemistry and Molecular Biology
Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration
Introduction
Phytoestrogens are a diverse group of plant-derived compounds that structurally and functionally mimic mammalian estrogens [1]. There are three major classes of phytoestrogens: the isoflavones, lignans, and coumestans. Of isoflavones, genistin and daidzin are the two most prevalent forms in soy foods. They are biologically inactive; once ingested, they are cleaved by glucosidases to “aglycones”, genistein (GTN) and daidzein (DZ) [2]. By intestinal microflora, GTN is further metabolized largely to non-estrogenic metabolites product, para-ethylphenol, while DZ is converted either to equol (EQL) or O-desmethylangolensin (ODMA) by two different metabolic pathways (Fig. 1) [3], [4], [5]. The new metabolites of DZ with additional hydroxyl groups have been recently identified but their levels were low in human urine [6], [7]. The metabolites undergo enterohepatic circulation after absorption. They can work in human body with the various estrogenic activities, often higher or lower than their precursors. There are some reports that show apparent inter-individual variation in the mode of metabolism with preference to EQL production in some individuals [5], [8], [9].
Phytoestrogens are known to have dual biologic functions; they can act estrogenically as estrogen agonists and antiestrogenically as antagonists [1]. The mechanism has not been completely clarified yet. A few in vivo data suggest that their biologic behavior may be modulated by the individual's amount of endogenous estrogens. Ingestion of a large amount of soy protein has been shown to suppress circulating female sex hormone levels and affect menstrual patterns in premenopausal women [10], [11]. Phytoestrogens, thus, may act primarily as an estrogen in a low-estrogen environment and as an estrogen competitor in a high estrogen environment.
Current evidence for the clinical usefulness of phytoestrogens is still controversial owing in part to their complex biological activity and the heterogeneity of the study populations, which results in individual metabolic variability. Well-characterized in vitro systems are needed to compare the diverse compounds including their metabolites for better understanding of their beneficial or adverse effects of an in vivo system on individual basis. We, therefore, analyzed and compared the in vitro biologic activities in a low or high estrogen environment. A few studies have been reported to evaluate estrogenic properties of isoflavones, which focused mostly on GTN or DZ [1], [12]. The biological characteristics of intermediate metabolites have not been fully assessed yet. Our study is first to determine the estrogen and antiestrogen activities of intermediate metabolites including tetrahydrodaidzein (TDZ), dihydrodaidzein (DDZ), and dihydrogenistein (DGTN).
Section snippets
Materials
17-β2-Estradiol (E2), 4-hydroxytamoxifen, hydroxyapatite (HAP), DZ (4′,7-dihydroisoflavone), and GTN (4′,5,7-trihydroxyisoflavone) were obtained from Sigma (St. Louis, Mo). Macrophage-cell stimulating factor (M-CSF) and soluble human receptor activator NFκ-B ligand (RANKL) were from Peprotech (Rocky Hill, NJ). Dual-Luciferase reporter assay system was purchased from Promega (Madison, WI). DGTN, DDZ, TDZ, EQL, and ODMA were synthesized and measured by liquid chromatography mass spectrometry
Results
Saturation ligand binding experiment with [3H]-E2 and linear transformation of saturation data revealed a single population of binding sites for E2 with Kd of 0.05 nM for the ERα and 0.08 nM for ERβ protein as shown in previous studies [16]. The binding affinities of the test compounds to the rhERα and β are shown in Table 1. All the compounds bound to both ER subunits. The relative binding affinity (RBA) of each compound was calculated as the ratio of concentrations of E2 and competitor required
Discussion
In our study, the estrogen agonist and antagonist properties of seven isoflavonoid derivatives were assessed in terms of their relative abilities to compete radiolabeled E2 for binding of ERα or β, to induce a transfected estrogen-responsive reporter gene and an estrogen target gene, to stimulate growth of the breast cancer cells, and to suppress osteoclast formation. The in vitro studies of phytoestrogens have focused especially on the biologic function especially of the two major soy
Acknowledgements
This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea. (A060030). The authors appreciate Dr. Hyun-Ah Choi for proofreading the manuscript.
References (27)
- et al.
Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability
Am. J. Clin. Nutr.
(2002) - et al.
Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6′-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography–mass spectroscopy using authentic reference compounds
Anal. Biochem.
(1999) - et al.
Metabolites of dietary soya isoflavones in human urine
Clin. Chim. Acta
(1993) - et al.
The clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones
J. Nutr.
(2002) - et al.
Metabolism of the soy isoflavones daidzein, genestein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton
J. Steroid Biochem. Mol. Biol.
(2003) - et al.
A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids
J. Steroid Biochem. Mol. Biol.
(1995) - et al.
Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
Am. J. Clin. Nutr.
(1994) - et al.
Hydroxylapatite “batch” assay for estrogen receptors: increased sensitivity over present receptor assays
J. Steroid Biochem.
(1976) - et al.
Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method
Methods
(2001) - et al.
Comparative study of oestrogenic properties of eight phytoestrogens in MCF-7 human breast cancer cells
J. Steroid Biochem. Mol. Biol.
(2005)
Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell
Toxicol. Appl. Pharmacol.
Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay
Toxicol. Lett.
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Am. J. Clin. Nutr.
Cited by (232)
Investigation of the estrogenic potential of 15 rosé, white and red wines via effect-directed ten-dimensional hyphenation
2023, Journal of Chromatography AExperimental and molecular docking studies of estrogen-like and anti-osteoporosis activity of compounds in Fructus Psoraleae
2021, Journal of Ethnopharmacology